Phase I/Ib Study of Olaparib and Carboplatin in Heavily Pretreated Recurrent High-Grade Serous Ovarian Cancer at Low Genetic Risk

Oncotarget - United States
doi 10.18632/oncotarget.26869
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Low-Stage High-Grade Serous Ovarian Carcinomas

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2016English

Proteome Profiling of Low Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Characterisation of Homologous Recombination Deficiency in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology
Oncology
2010English

PAX2 Expression in Low Malignant Potential Ovarian Tumors and Low-Grade Ovarian Serous Carcinomas

Modern Pathology
Forensic MedicinePathology
2009English

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy